URMC / Department of Biostatistics and Computational Biology / People & Research / Faculty / Derick Peterson, PhD

Derick Peterson, PhD

Derick Peterson, PhD Professor of Biostatistics and Computational Biology
Professor of Oncology
Co-Director, Biostatistics and Bioinformatics Shared Resource for the Wilmot Cancer Institute

Contact Information:

University of Rochester
Dept of Biostatistics and Computational Biology
265 Crittenden Boulevard, CU 420630
Rochester, New York 14642-0630

Office: Saunders Research Building 4132
Phone: (585) 275-6686
Fax: (585) 273-1031
E-mail: Derick_Peterson (at) urmc.rochester.edu

Research Interests

Methodological research topics of particular interest to me include the construction of prognostic gene expression profiles from high-dimensional transcriptomic data, model selection, nonparametric estimation and inference, data-driven smoothing methods, and the analysis of censored survival data.

My experience in applied medical & epidemiological research has focused on cancer, cardiology, and infectious respiratory diseases.

I joined the Biostatistics faculty at the University of Rochester in 1998, directly after receiving my PhD in Biostatistics from UC-Berkeley, under the supervision of Prof. Mark J. van der Laan and Prof. Kjell A. Doksum.

Technical reports

Peterson, D. (2006). Constructing Multivariate Prognostic Gene Signatures with Censored Survival Data. (Technical Report 06/09).

Selected Publications

Wang M, Peterson DR, Pagan E, Bagnardi V, Mazzanti A, McNitt S, Rich DQ, Seplaki CL, Kutyifa V, Polonsky B, Barsheshet A, Kukavica D, Rosero S, Goldenberg I, Priori SG, Zareba W (2022). Assessment of absolute risk of life-threatening cardiac events in Long QT Syndrome patients. Frontiers in Cardiovascular Medicine, section Cardiac Rhythmology
Steinberg J, Gorcsan J, Mazur A, Jain SK, Rashtian M, Greer GS, Zarraga I, Vloka M, Cook MM, Salam T, Mountantonakis S, Beck H, Silver J, Aktas M, Henrikson C, Schaller RD, Epstein AE, McNitt S, Schleede S, Peterson D, Goldenberg I, Zareba W (2022). Junctional AV ablation in patients with atrial fibrillation undergoing cardiac resynchronization therapy (JAVA-CRT): results of a multicenter randomized clinical trial pilot program. Journal of Interventional Cardiac Electrophysiology 2022 Jan 18:112. doi: 10.1007/s10840-021-01116-6. Epub ahead of print. PMID: 35043250; PMCID: PMC8765764.
Pinney JJ, Blick-Nitko SK, Baran AM, Peterson DR, Whitehead HE, Izumi R, Munugalavadla V, VanDerMeid KR, Barr PM, Zent CS, Elliott MR, Chu CC (2022). The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact. Haematologica 2022 Feb 17. doi: 10.3324/haematol.2021.279560. Epub ahead of print. PMID: 35172559.
Mazzanti A, Trancuccio A, Kukavica D, Pagan E, Wang M, Mohsin M, Peterson D, Bagnardi V, Zareba W, Priori SG (2022). Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors’ reply. Europace. 2022 Apr 5;24(4):698-699. doi: 10.1093/europace/euac013. PMID: 35303087.
Kerns SL, Morlang AA, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein B, Gomez-Caamano A, Vega A, Parker C, Veldeman L, Talbot CJ, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Choudhury A, Elliott RM, Sperk E, Rancati T, Azria D, Chang-Claude J, Seibold P, West C, REQUITE Consortium, Janelsins M, Chen Y, Messing E, Morrow G (2022). Use of Angiotensin Converting Enzyme Inhibitors is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer. Radiotherapy and Oncology S0167-8140(22)00018-4. doi: 10.1016/j.radonc.2022.01.014.
Huselton E, Torres N, Baran A, Burrows K, Liesveld J, Mendler J, Peterson D, Langstein H, Evans A, Becker M, Aljitawi O (2022). Interim Analysis of a Pilot Study Evaluating the Safety and Tolerability of Hyperbaric Oxygen Therapy in Combination with Fludarabine and Melphalan Conditioning and Allogeneic Hematopoietic Cell Transplant (2022). Transplantation and Cellular Therapy Volume 28, Issue 3, Supplement, March 2022, Pages S360-S361. https://doi.org/10.1016/S2666-6367(22)00620-0
Bjelic M, Zareba W, Peterson DR, Younis A, Aktas MK, Huang DT, Rosero S, Cutter K, McNitt S, Xia X, MacKecknie BD, Horn R, Sotoodehnia N, Kudenchuk PJ, Rea TD, Arking DE, Wilde AAM, Shimizu W, Ackerman MJ, Goldenberg I (2022). Sex Hormones and
Repolarization Dynamics during the Menstrual Cycle in Women with Congenital Long QT Syndrome. Heart Rhythm (in press).
Wang M, Peterson DR, Rosero S, McNitt S, Rich DQ, Seplaki CL, Polonsky B, Goldenberg I, Zareba W (2021). Effectiveness of Implantable Cardioverter Defibrillators to Reduce Mortality in Patients with Long QT Syndrome. Journal of the American College of Cardiology 78(21):2076–2088. doi: 10.1016/j.jacc.2021.09.017
Peterson DR, Baran AM, Bhattacharya S, Branche AR, Croft DP, Corbett AM, Walsh EE, Falsey AR, Mariani TJ (2021). Gene Expression Risk Scores for COVID-19 Illness Severity. Journal of Infectious Diseases 2021 Nov 30:jiab568. doi: 10.1093/infdis/jiab568. Epub ahead of print. PMID: 34850892; PMCID: PMC8767880.
Mazzanti A, Trancuccio A, Kukavica D, Pagan E, Wang M, Mohsin M, Peterson D, Bagnardi V, Zareba W, Priori SG (2021). Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk). EP Europace euab238, https://doi.org/10.1093/europace/euab238.
Branche AR, Saiman L, Walsh EE, Falsey AR, Sieling WD, Greendyke W, Peterson DR, Vargas CY, Phillips M, Finelli L (2021). Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2020. Clinical Infectious Diseases 2021 Jul 9;ciab595. PMID:34244735. DOI: 10.1093/cid/ciab595.
Bhattacharya S, Mereness JA, Baran AM, Misra RS, Peterson DR, Ryan RM, Reynolds AM, Pryhuber GS, Mariani TJ (2021). Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia. Frontiers in Immunology 11:563473. doi:10.3389/fimmu.2020.563473. eCollection 2020.